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ORIGINAL ARTICLE
Strong Prognostic Value of Tumor-infiltrating
Neutrophils and Lymphocytes Assessed by
Automated Digital Image Analysis in Early
Stage Cervical Cancer: A Comparator Study
with Observer-assisted Stereological
Assessments
Andreas Carus, Ph.D., Frede Donskov, DMSc, Patricia S Nielsen, Ph.D.,
Henrik Hager, Ph.D., Bettina S Nedergaard, Ph.D., Torben Steiniche,
Prof, DMSc, and Morten Ladekarl, DMSc
Abstract
INTRODUCTION
Manual observer-assisted stereological (OAS) assessments of tumor-infiltrating
neutrophils and lymphocytes are prognostic, accurate, but cumbersome. We
assessed the applicability of automated digital image analysis (DIA).
METHODS
Visiomorph software was used to obtain DIA densities of immunostains for
CD66b+ neutrophils, CD163+ macrophages, and CD8+ lymphocytes in tumors from
101 patients with International Federation of Gynecology and Obstetrics (FIGO)
stage IB/IIA cervical cancer. Results were compared with manual OAS assessments.
RESULTS
Automated DIA assessment was faster and required less human resources than
manual OAS assessments. We observed high correlations between DIA and OAS
variables for CD8+ lymphocytes, CD66b+ neutrophils, and CD163+ macrophages
(spearman ρ > 0.8; P < 0.0001).
Hazard rates for recurrence of DIA assessments in the global tumor area were
comparable with the prognostically strongest manual OAS assessments in the
peritumoral compartment. In multivariate analysis, CD66b and CD8 densities,
assessed by DIA, and regional lymph node metastases were independent predictors
of RFS, while CD163 density and FIGO stage were not. The CD66b/CD8 tumor-
associated neutrophil to lymphocyte (TA–NL) index accurately predicted the risk of
relapse, ranging from 8% to 52% (P  0.001).
CONCLUSIONS
DIA is a potential assessment technique. The TA–NL index obtained by DIA is a
strong prognostic variable with possible routine clinical application.
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Cervical cancer remains a cause of morbid-ity and mortality in women even with theintroduction of screening and vaccine
programs. Prognostic markers for patient out-
come in localized cervical cancer consist of
clinicopathological features although tissue bio-
markers are emerging.1,2 The introduction of
new prognostic markers is warranted for im-
proved patient care. Immune infiltrates have
emerged as potential prognostic factors in a
range of cancers.3 In previously published
studies by our group in patients with early stage
cervical cancer we demonstrated that high
densities of tumor-infiltrating lymphocytes were
associated with a favorable recurrence-free sur-
vival (RFS) whereas high densities of tumor-
associated CD66b+ neutrophils were associated
with a poor PFS.4–6 These results were obtained
by an observer-assisted stereological (OAS)
method that is accurate and reproducible7 but
labor intensive and requires specialized train-
ing.8,9 For clinical relevance and applicability
more efficient methods are warranted.
Digital image analysis (DIA) is an emerging,
high-throughput method for automated quan-
titative assessments of immunostained sec-
tions. Software for automated DIA of whole
slide images has evolved rapidly and allows
for fast quantification of the distribution of
immunohistochemical (IHC)-stained cells or
structures within a large area in less time and
with reduced workload compared to observer-
assisted methods.9 Care has to be taken as
DIA protocols are still sensitive to variation by
tissue processing, IHC protocols, unspecific
staining, and definition of region of interest
(ROI).8,10,11
In the present study, we developed automated
DIA protocols for quantifying CD66b neutro-
phils, CD163 macrophage, and CD8 lymphocyte
immunostains in the same cohort of early stage
cervical cancer patients as previously assessed
with the OAS method. We found automated DIA
provided clinically applicable prognostic infor-
mation comparable to the considerably more
cumbersome manual OAS methods in a fast,
efficient, and robust manner.
MATERIALS AND METHODS
The study included 101 consecutive patients
treated with surgery (N  87) or definitive
radiotherapy (N  14) for cervical squamous
cell type carcinoma of International Federation
of Gynecology and Obstetrics (FIGO)12 stage IB
(N  91) and IIA (N  10) at Aalborg Hospital,
Denmark, from 1990 to 2000.4 Clinical sub-
classification in stage IB1 and IB2 was not
available. Mean age was 44 years (22–70 years).
If operable, patients underwent hysterectomy
with pelvic lymph node dissection and in cases
of increased risk of relapse, radiotherapy was
added. Inoperable patients were treated by defi-
nitive radiotherapy (combined external radio-
therapy and brachytherapy). At the time of
surgery 18 patients had lymph node meta-
stases. Adjuvant radiotherapy was given to
23 patients. Median follow-up was 9.8 years;
for patients alive minimum follow-up was at
least 5 years. During the follow-up period a total
of 31 patients relapsed. Tumor samples were
collected from the blocks used for routine patho-
logic evaluation. If patients were treated with
definitive radiotherapy biopsy material was col-
lected, otherwise whole tumor blocks were re-
trieved. We aimed at analyzing two tumor sections
from each patient; however, in 16 patients (16%)
only one section was available.
The study was approved by the local Ethics
Committee (Case number M-20100011; date 9
February 2010).
immunohistochemistry
Formalin-fixed, paraffin-embedded tumor speci-
mens were sectioned at 2 mm and mounted on
glass slides. Primary antibodies were against
CD66b (clone G10F5, 1:600, no. 555723, BD
Biosciences, United States), CD163 (clone
EDHu-1, 1:100, MCA 1853, Abd Serotec, United
Kingdom), and CD8 (Clone C8/144B, 1:250,
M 7103, Dako). Immunohistochemistry was
performed using a Benchmark XT automated
stainer (Ventana Medical Systems, Tucson, AZ,
United States). Sections were counterstained
with haematoxylin and bluing reagent. The IHC
protocols have previously been described in
detail.4,5
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quantitative evaluation of immunostaining
Whole slide images were captured by NanoZoomer
2.0 (Hamamatsu Photonics K.K., Hamamatsu
City, Japan) using the 20 magnification mode.
The global tumor area including the tumor
area and adjacent tumor-associated stroma de-
fined at low screen magnification, excluding
areas of large necroses was outlined as ROI by
the observer (Fig. 1A). Generally necrotic areas
were scarce and in almost all cases no adjust-
ment for necroses was performed. In four
sections, some necrotic areas were observed
with a degree of peri-necrotic infiltration of
CD66b+ neutrophils. However, in theses sections
the global tumor area was highly infiltrated by
CD66b+ neutrophils and consequently a correc-
tion for peri-necrotic infiltration was not deemed
necessary. We did observe CD66b IHC staining
of the necrotic areas but little CD163 staining.
For DIA, three automated protocols were
developed using Visiomorph DP software (Vis-
iopharm, Denmark) for assessing the densities
of CD66b (Fig. 1B), CD163, and CD8 immu-
nostains, respectively (i.e. the area of immu-
nostain divided by the tissue area within the
ROI).
Figure 1. (A) The Digital Image Analysis (DIA) Allows for Discrimination between Tissue (Blue Area) and Irrelevant Space
within the Region of Interest (ROI) (Yellow Line) (resolution 20x). (B) DIA Determines the Density of Immunostain
(Orange) Relative to Tissue (resolution 400x).
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The protocols were devised by assessing 8–10
representative sections and encompassed a series
of preprocessing steps (enhancement of red–
green–blue color levels and, if relevant, Diami-
nobenzidine (DAB) deconvolution), segmenta-
tion (Bayesian classifier), and post-processing
steps (mainly morphological operations).
OAS assessments of immune cells in three,
nonoverlapping tumor compartments (tumor
nests, peritumoral and stromal compartments,
respectively), were obtained using computer-
aided, unbiased stereological sampling techni-
ques (newCAST software, Visiopharm, Den-
mark), as described in detail previously.4 An
area of stroma was denoted peritumoral, if at
least one malignant cell was observed in the field
of view inside a sampling frame. If no tumor
cells were observed the area was denoted as
stromal. The OAS assessment of CD163+ macro-
phages was performed by point counting yield-
ing a density of CD163+ immunostain per area of
tissue, as macrophages are often elongated and
fragmented rendering individual cell delineation
impossible. In contrast, OAS assessments of
CD66b+ neutrophil and CD8+ lymphocyte were
performed as cell profile counts per area of
tissue. For comparison with DIA, results of OAS
variables obtained in the global tumor area were
calculated from the sum of estimates in all
compartments of the tumor, weighted according
to sampling intensity.
statistics
The DIA assessments of CD66b, CD163, and
CD8 immunostains were positively skewed and
some assessments had a value of 0. Therefore,
log-transformation after adding a constant of 1
was applied to achieve approximate normality.13
Nonparametric spearman rank test was per-
formed to investigate correlations between non-
transformed DIA assessments and OAS assess-
ments. Pearson correlation tests were also
performed on the log-transformed values but
yielded similar results (data not shown). A linear
regression analysis was performed to compare
log-transformed values of OAS and DIA assess-
ments of CD163+ macrophage immunostain.
A nonparametric Mann–Whitney test was per-
formed to compare variables obtained in patients
with and without lymph node metastases. For
prognostic analyses, variables were dichoto-
mized at medians or quartiles. Univariate Cox
regression models were used to assess the
hazard ratio (HR) of the DIA and OAS variables.
OAS assessments performed in the peritumoral
compartment, which in our previous study
generally had the highest discriminatory power,4
were included in the prognostic models for
comparison. A Cox proportional hazards model
was created to identify independent predictors of
RFS, including DIA immunostain densities of
CD66b+ neutrophils, CD163+ macrophages, and
CD8+ lymphocytes, as well as clinical prognostic
variables.
Statistical analyses were performed using
SPSS version 20.0 (SPSS, Chicago, IL, United
States) statistical software. All tests were two-
sided and P values less than .05 were considered
statistically significant.
RESULTS
The patient demographics and clinicopathologi-
cal features are summarized in Table 1.
In univariate analysis increased infiltration of
CD66b+ neutrophils (HR 2.9; 95% CI 1.3–6.3;
P  0.007) and low densities of CD8+ lympho-
cytes (HR 2.4; 95% CI 1.1–5.1; P  0.02)
assessed by automated DIA were significantly
associated with poor RFS. Increased infiltration
of CD163+ macrophages was not significant
(P  0.06) in univariate analysis. These results
obtained by DIA were comparable to previously
obtained OAS measurement results assessed in
Table 1. Patient Characteristics (N  101).
Without
recurrence Recurrence
Number of patients 70 (69%) 31 (31%)
Age at diagnosis (range),
years
45 (26–68) 41 (22–70)
Stage IB 63 (90%) 28 (91%)
Stage IIA 7 (10%) 3 (9%)
Lymph node metastases
No 62 (89%) 21 (68%)
Yes 8 (11%) 10 (32%)
Primary treatment
Surgery 61 (87%) 26 (85%)
+Adjuvant radiotherapy 13 (21%) 10 (38%)
Radiotherapy 9 (13%) 5 (15%)
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the peritumoral compartment4 (shown for com-
parison in Table 2).
For an experienced observer, time spent to
obtain OAS densities of immune cells by manual
cell counting, using a sampling frame with
associated sampling points in automatically
selected fields of visions, was approximately
2 min for delineation of the sampling area and
roughly 15 min per cell variable per patient. In
contrast, total observer time spend for DIA was
only approximately 2 min per patient, used for
delineation of the ROI. Computation runtime for
a single slide was 2–15 min, and the total
analysis of an unlimited number of slides could
be performed at any time, day or night, with no
request of observer assistance.
We observed high correlations between DIA
and OAS variables of corresponding parameters
(Fig. 2A–C). For CD8+ lymphocytes spearman
ρ was 0.79 (95% CI 0.68–0.87; P < 0.0001);
for CD66b+ neutrophils spearman ρ was 0.85
(95% CI 0.75–0.91; P < 0.0001); and for CD163+
macrophages spearman ρ was 0.92 (95% CI
0.88–0.95; P < 0.0001). The CD8+ lymphocyte
and CD66b+ neutrophil assessments obtained by
the two methods are not directly comparable,
since the DIA yields an immunostain area
fraction, whereas the OAS counts produces a
numerical density of immunostained cells per
tissue area.4 Hence, the correlation between
these variables is not expected to be linear,
best illustrated in Figure 2A for neutrophils.
Linear regression analysis of the similar DIA-
obtained and OAS-obtained CD163+ macrophage
immunostain densities revealed an excellent
correlation (R2  0.86; P < 0.0001; Fig. 2C).
A multivariate Cox proportional-hazard re-
gression model was used to analyze the relative
strength of DIA assessments of CD66b+ neutro-
phils, CD163+ macrophages, and CD8+ lympho-
cytes in addition to FIGO stage and lymph node
status. High density of CD66b immunostain (HR
2.6; 95% CI 1.2–5.7; P  0.02), low density of
CD8 immunostain (HR 2.3; 95% CI 1.1–4.9;
P  0.03), and presence of lymph node meta‐
stases (HR 2.6; 95% CI 1.2–5.5; P  0.02) were
significant independent factors associated with
of poor RFS, whereas clinical stage and CD163
immunostain density were not.
The CD66b/CD8 tumor-associated neutrophil
to lymphocyte (TA–NL) index obtained by DIA
had excellent discriminatory power for each
quartile with 5-year RFS of 92%, 80%, 65%,
and 48% for quartile I (<0.019), II (0.02–0.05),
III (0.06–0.24), and IV (>0.25), respectively (P 
0.001; Fig. 3).
The DIA CD163+ macrophage immunostain
density was significantly lower in patients with
lymph node metastases (median 0.9% (95% CI
0.6–1.6%)) compared to those without (median
2.0% (95% CI 0.9–3.3%)) (P  0.007), but the
two groups CIs were overlapping. No significant
correlation among CD66b+ and CD8+ immunos-
tain densities and lymph node metastases was
observed.
DISCUSSION
In the present study, we demonstrated assess-
ment of a CD66b/CD8 TA–NL index obtained by
automated DIA accurately predicted the risk of
relapse for early stage cervical cancer patients.
Automated DIA is a fast and efficient method
compared to manual assessments and has
potential for routine application. This study is
the first direct comparison between an auto-
mated and manual IHC assessment in cervical
cancer and validates our previous findings of the
prognostic impact of tumor-associated immune
cells.3–5
Table 2. Univariate Comparison of Prognostic Impact with Respect to Recurrence-Free Survival (RFS) of Cervical
Carcinoma, for Digital Image Analysis (DIA) Assessments in the Global Tumor Area and for Previously Obtained
Observer-Assisted Stereological (OAS) Assessments in the Peritumoral Compartment. CD66b+ Neutrophils, CD163+
Macrophages, and CD8+ Lymphocytes, Stratified at Median.
Risk factor Median cutoff DIA (HR) OAS (HR)
CD66b+ > vs. ≤ 2.9 (1.3–6.3; P  0.007) 2.1 (1.0–4.5; P  0.04)
CD8+ ≤ vs. > 2.4 (1.1–5.1; P  0.02) 3.4 (1.5–7.7; P  0.003)
CD163+ > vs. ≤ 2.0 (0.97–4.2; P  0.06) 2.1 (1.0–4.4; P  0.05)
Hazard ratio (HR) for RFS (95% CI; P value); vs.  versus.
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The prognostic importance of the tumor
immune infiltrate has emerged in many cancer
types. High numbers of tumor-associated
CD66b+ neutrophils and CD163+ M2 macro-
phages have been correlated with poor outcome
in several malignant diseases,14–16 although
some results have been conflicting.17,18 Neutro-
phils are involved in crucial steps for cancer
development, including increased carcinogen-
esis, initiation of the angiogenic switch, extra-
vasation of tumor cells, and formation of the
“premetastatic niche”.14 In murine studies tu-
mor-associated neutrophils (TAN) have been
observed to polarize into N1 neutrophils with
antitumor activity and N2 neutrophils with
tumor-promoting properties.19 If polarizations
of TANs occur in human tumors are unclear. The
tumor sections in the present study were re-
viewed by a senior pathologist (T.S.) and close to
all cells with morphological resemblance of
segmented neutrophils stained positively for
CD66b. No significant morphological heteroge-
neity of neutrophils was observed. CD66b is a
marker of neutrophil activation, but whether
CD66b stain all TANs or only a subset of TANs
is unknown. The number of tumor-promoting
neutrophils relative to tumor-antigen-responsive
mononuclear cells may predict patient outcome
as suggested by studies of these cells in the
peripheral circulation of cancer patients.14,16,20
Lymphocytes infiltrating cervical cancers and
other gynecological cancers have been recognized
as prognostically favorable for decades,21–24 and
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Figure 2. Scatterplots of log+1-transformed Values for Immunostain Density Assessments Performed by Automated DIA
in the Global Tumor Area (y Axis) Versus Corresponding Variables Obtained by Observer-assisted Stereology (OAS) in the
Peritumoral Compartment (x Axis). (A) CD66b+ Immunostain Density vs. Numerical Density of CD66b+ Neutrophils.
(B) CD163+ Macrophage Immunostain Densities Obtained by DIA vs. OAS. (C) CD8+ Immunostain Density vs. Numerical
Density of CD8+ Lymphocytes.
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virus-associated antigens and oncogenes seems
reflected by the composition, localization, and
numbers of specific types of tumor-infiltrating
lymphocytes in situ. For example, in CIN 2–3
lesions HPV-16 infection correlated with low
numbers of CD8+ lymphocytes, and the number
of stromal CD8+ lymphocyte was an independent
regression predictor.25 We demonstrated in
previous studies of manual stereological assess-
ments of CD8+ lymphocytes and CD66b+ neu-
trophils excellent prognostic information of the
composition of the immune infiltrate with some
tumor compartment variation. In this novel
study of automated DIA analysis in the global
tumor compartment, we demonstrated a prog-
nostic impact of a tumor-associated CD66b/
CD8 immunostain index with possible clinical
applicability. This could identify high-risk
patients, who may benefit the most from adju-
vant treatment.26,27
In recent years it has become increasingly
clear that in addition to cancer cells, a tumor
lesion contains a number of recruited normal
cells that contribute to the hallmarks of cancer
by creating the tumor microenvironment.28
Stromal cells, blood vessels and infiltrating
inflammatory cells are major components of
the tumor microenvironment.29 These cells en-
able and sustain most of the hallmarks of cancer
through reciprocal communications with neo-
plastic cancer cells.30 A leukocyte infiltrate,
comprising mast cells, T cells, natural killer
cells, T-regulatory cells, myeloid-derived sup-
pressor cells, tumor-associated macrophages,
and TANs are key participants of the tumor
microenvironment where they can promote or
inhibit cancer formation and development.31–33
The novelty of the present study is to provide a
fast, efficient assessment method to identify
key prognostic components of the tumor micro-
environment in cervical cancer making this
information potentially clinically translatable.
Modification of the tumor microenvironment
may be a target for therapeutics.34,35
Variables obtained by DIA in the global tumor
area and by the OAS technique in the peritumor-
al compartment had similar power to identify
subgroups of patients with poor and favorable
prognosis. OAS assessments of tumor-associated
leukocytes obtained at the “invasion front”, that
is, in the peritumoral compartment was the
prognostically most informative in our OAS
assessments. In contrast, a simple DIA observa-
tion obtained in the global tumor compartment
provided similar prognostic information. How-
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Figure 3. Kaplan–Meier Plots of RFS of 101 Patients with Localized Cervical Squamous Cell Carcinoma According to the
CD66b/CD8 Immunostain (TA–NL) Index in the Global Tumor Area Divided at Quartiles. P value Obtained from Log-Rank
Test.
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the global tumor area is rapidly defined with ease
and therefore DIA has potential for routine use.
Software solutions associating immunostains to
individual cells of specific morphological types
are in some instances available,9 but the robust-
ness of automated morphological cell identifica-
tion is debatable and must be validated for
specific cell types and protocols. Double staining
methods may be applicable in some instances as
have been shown in malignant melanoma for
DIA assessments of the frequency of Ki67 and
phosphohistone expression in MART1(Melan-A)-
positive tumor cells.36
Even for an experienced observer the observer
time consumption was reduced substantially
with DIA compared with a manual observer-
assisted method (OAS) method. Variables ob-
tained by DIA and by the OAS techniques had
similar ability to identify subgroups of patients
with poor and favorable prognosis. In particular,
the CD66b/CD8 TA–NL index obtained by DIA
had excellent discriminatory power, identifying
precisely the risk of cancer recurrence in each
quartile of the index. This immune cell index
seems highly suited for routine application,
robust to heterogeneity and automatically ob-
tainable after quick and simple outlining of an
easily definable ROI. It is obtainable by a trained
technician and, potentially, in a single double-
immunostained section. Still, DIA protocols may
be sensitive to variations in tissue processing and
staining protocols,8,10,11 and the interlaboratory
reproducibility of measurements should there-
fore be investigated further.
A limitation to our study was the retrospective
design and heterogeneity of treatments and
amount of tumor tissue available for analysis.
However, patients were treated consecutively in a
single institution. We did not observe any impact
on our results of treatment modality or whether
one or two tumor sections were available.
In early stage cervix cancer additional prog-
nostic factors are needed to identify high-risk
patients. The results of the CD66b/CD8 TA–NL
index obtained by DIA are promising and should
be validated prospectively in future studies.
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